pharma

Showing 15 posts of 2914 posts found.

fda2outsideweb

AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer

January 15, 2018
Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma

The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …

flu

Universal flu vaccine receives Google’s financial backing

January 15, 2018
Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical

Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …

kid_ill

FDA steps in to prohibit codeine cough syrups for children

January 12, 2018
Medical Communications FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are …

roche_close

Roche’s Ocrevus gets the go ahead in Europe for two forms of MS

January 12, 2018
Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …

old_man_bar

Another Alzheimer’s drug bites the dust in P3

January 12, 2018
Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and

barrett_novartis

Novartis prises Pfizer’s Oncology Head away

January 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

teva_small

Teva execs feel the pinch, after pay halved

January 11, 2018
Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …

AZ’s Fasenra approved in Europe as an add-on for severe eosinophilic asthma

January 11, 2018
Research and Development AstraZeneca, European Commission, Fasenra, MedImmune, asthma, pharma

AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …

truvada-web

AIDS charity lambasts “ethically challenged” Gilead over price hikes

January 11, 2018
Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical

The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …

mr058666-web

Nestle reportedly pulls out in front to buy Merck KGaA consumer health unit with $5 billion bid

January 11, 2018
Sales and Marketing Merck KGaA, nestle, pharma

It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …

nhs_sign

NHS no longer able to deliver on standards, warn bosses

January 11, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

The struggles of the NHS this winter are no secret, especially after being front and centre of the first Prime …

Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations

January 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …

hands-981400_960_720

New project examining FDA-approved drugs for Alzheimer’s, worries over research remains

January 10, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …

xarelto_10_tablet1

Bayer and J&J successfully reverse $28 million Xarelto court payout

January 10, 2018
Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma

Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …

mit-drug-delivery-01_0

Slow-release, once-weekly pill for HIV developed

January 10, 2018
Research and Development HIV, Lyndra, biotech, drugs, pharma, pharmaceutical

Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not …

The Gateway to Local Adoption Series

Latest content